Blog
RSS FeedPosted by Michael Wonder on 25 Jul 2016
NICE approves Servier’s Lonsurf as third-line cancer therapy
25 July 2016 - The National Institute for Health and Care Excellence has recommended trifluridine/tipiracil as an option for treating metastatic ...
Posted by Michael Wonder on 24 Jul 2016
Cancer experts write to government to demand life saving drug be used on NHS
24 July 2016 - Cancer specialists from around the UK have written to the Government’s health watchdog to demand a potentially ...
Posted by Michael Wonder on 21 Jul 2016
pERC issues final recommendation for Imbruvica (ibrutinib)
19 July 2016 - Canada's pCODR Expert Review Committee has issued a final recommendation for Janssen's ibrutinib for patients with ...
Posted by Michael Wonder on 21 Jul 2016
Lilly’s Alimta wins NICE support
21 July 2016 - NHS use of Eli Lilly's Alimta to treat patients with lung cancer has been endorsed in final ...
Posted by Michael Wonder on 20 Jul 2016
Breakthrough lung cancer drug must be available on NHS, AstraZeneca says
20 July 2016 - A breakthrough lung cancer drug developed by UK scientists, which passed final clinical trials this week, might ...
Posted by Michael Wonder on 20 Jul 2016
Decision to award sole supply of progestogen-only long-acting intra-uterine system (LIUS) in the community and DHB hospitals
20 July 2016 - PHARMAC is pleased to announce the approval of a sole supply agreement with Bayer New Zealand Limited ...
Posted by Michael Wonder on 20 Jul 2016
NICE publishes final guidance recommending ataluren for children with Duchenne muscular dystrophy
20 July 2016 - NICE has published final guidance recommending ataluren for treating children aged 5 and over with Duchenne muscular ...
Posted by Michael Wonder on 18 Jul 2016
Diabetes drugs cost the NHS in Scotland almost £90 million last year
16 July 2016 - Diabetes drugs cost the NHS in Scotland almost £90 million last year amid fears that public health ...
Posted by Michael Wonder on 18 Jul 2016
Report on the collection of under co-payment data 2014-15
18 July 2016 - The report on the collection of under co-payment data 2014-15 is now available. ...
Posted by Michael Wonder on 18 Jul 2016
Summary of price disclosure outcomes for the 2016 October cycle
18 July 2016 - The summary of price disclosure price reductions for the 2016 October Cycle (First Remove Originator cycle) has ...
Posted by Michael Wonder on 17 Jul 2016
Londoner’s crowdfunding bid for £200,000 vital cancer drug
15 July 2016 - A young Londoner with advanced cancer today told how he turned to crowdfunding to raise £200,000 for ...
Posted by Michael Wonder on 17 Jul 2016
Diabetics fear for health after government removes blood sugar test subsidy
17 July 2016 - Diabetics will pay 50 times more for strips that help them monitor their blood sugar levels after ...
Posted by Michael Wonder on 16 Jul 2016
Outcomes from the May 2016 PTAC meeting
15 July 2016 - The outcomes from the May 2016 PTAC meeting are now available. ...
Posted by Michael Wonder on 16 Jul 2016
Agenda for the 20 July 2016 TC meeting
15 July 2016 - The Transparency Commission will consider the reimbursement of new medicines and blood products. ...
Posted by Michael Wonder on 15 Jul 2016
NICE rejects United Therapeutics’ cancer drug
15 July 2016 - NICE has rejected United Therapeutics’ Unituxin (dinutuximab) in combination therapy to treat a rare cancer affecting children ...